Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edward J A Douglas

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Microbiology (Reading, England)|September 1, 2023
Staph wars: the antibiotic pipeline strikes backEdward J A Douglas, Maisem Laabei
Microbiology (Reading, England)|June 2, 2026
Metabolic reprogramming promotes <i>Staphylococcus aureus</i> serum resistanceSamuel J Fenn, Edward J A Douglas, Ruth C Massey
Microbiology (Reading, England)|October 7, 2021
The MpsB protein contributes to both the toxicity and immune evasion capacity of <i>Staphylococcus aureus</i>Edward J A Douglas, Seána Duggan, Tarcisio Brignoli, et al.
Microbiology (Reading, England)|May 22, 2025
Anti-staphylococcal fatty acids: mode of action, bacterial resistance and implications for therapeutic applicationEdward J A Douglas, Nathanael Palk, Emily R Rudolph, et al.
Antimicrobial Agents and Chemotherapy|July 15, 2020
Resistance to Ceftazidime/Avibactam plus Meropenem/Vaborbactam When Both Are Used Together Is Achieved in Four Steps in Metallo-β-Lactamase-Negative Klebsiella pneumoniaePunyawee Dulyayangkul, Edward J A Douglas, Filip Lastovka, et al.
Microbial Biotechnology|May 13, 2023
Novel antimicrobial strategies to treat multi-drug resistant Staphylococcus aureus infectionsEdward J A Douglas, Sri W Wulandari, Scott D Lovell, et al.
Microbiology (Reading, England)|July 2, 2026
Commonly prescribed medicines antagonise anti-MRSA antibiotics and select for resistanceZoha Sohail, Henry A Claireaux, Andrew M Edwards, et al.
Antimicrobial Agents and Chemotherapy|April 22, 2020
Mutation of <i>kvrA</i> Causes OmpK35 and OmpK36 Porin Downregulation and Reduced Meropenem-Vaborbactam Susceptibility in KPC-Producing Klebsiella pneumoniaePunyawee Dulyayangkul, Wan Ahmad Kamil Wan Nur Ismah, Edward J A Douglas, et al.
Journal of Medical Microbiology|March 27, 2026
Polymyxin heteroresistance in <i>Klebsiella oxytoca</i>Eunice A Ayerakwa, Edward J A Douglas, Gerald Larrouy-Maumus, et al.
Frontiers in Microbiology|September 8, 2022
Antibacterial activity of novel linear polyamines against <i>Staphylococcus aureus</i>Edward J A Douglas, Abdulaziz H Alkhzem, Toska Wonfor, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Microbiology (Reading, England)|September 1, 2023
Staph wars: the antibiotic pipeline strikes backEdward J A Douglas, Maisem Laabei
Microbiology (Reading, England)|June 2, 2026
Metabolic reprogramming promotes <i>Staphylococcus aureus</i> serum resistanceSamuel J Fenn, Edward J A Douglas, Ruth C Massey
Microbiology (Reading, England)|October 7, 2021
The MpsB protein contributes to both the toxicity and immune evasion capacity of <i>Staphylococcus aureus</i>Edward J A Douglas, Seána Duggan, Tarcisio Brignoli, et al.
Microbiology (Reading, England)|May 22, 2025
Anti-staphylococcal fatty acids: mode of action, bacterial resistance and implications for therapeutic applicationEdward J A Douglas, Nathanael Palk, Emily R Rudolph, et al.
Antimicrobial Agents and Chemotherapy|July 15, 2020
Resistance to Ceftazidime/Avibactam plus Meropenem/Vaborbactam When Both Are Used Together Is Achieved in Four Steps in Metallo-β-Lactamase-Negative Klebsiella pneumoniaePunyawee Dulyayangkul, Edward J A Douglas, Filip Lastovka, et al.
Microbial Biotechnology|May 13, 2023
Novel antimicrobial strategies to treat multi-drug resistant Staphylococcus aureus infectionsEdward J A Douglas, Sri W Wulandari, Scott D Lovell, et al.
Microbiology (Reading, England)|July 2, 2026
Commonly prescribed medicines antagonise anti-MRSA antibiotics and select for resistanceZoha Sohail, Henry A Claireaux, Andrew M Edwards, et al.
Antimicrobial Agents and Chemotherapy|April 22, 2020
Mutation of <i>kvrA</i> Causes OmpK35 and OmpK36 Porin Downregulation and Reduced Meropenem-Vaborbactam Susceptibility in KPC-Producing Klebsiella pneumoniaePunyawee Dulyayangkul, Wan Ahmad Kamil Wan Nur Ismah, Edward J A Douglas, et al.
Journal of Medical Microbiology|March 27, 2026
Polymyxin heteroresistance in <i>Klebsiella oxytoca</i>Eunice A Ayerakwa, Edward J A Douglas, Gerald Larrouy-Maumus, et al.
Frontiers in Microbiology|September 8, 2022
Antibacterial activity of novel linear polyamines against <i>Staphylococcus aureus</i>Edward J A Douglas, Abdulaziz H Alkhzem, Toska Wonfor, et al.
Pageof 2